The phenotypic spectrum associated with OTX2 mutations in humans.

Area of Science:

• Developmental biology
• Genetics
• Endocrinology

Background:

• The OTX2 transcription factor is crucial for ocular, craniofacial, and pituitary development.
• Understanding OTX2's role is key to diagnosing and treating congenital hypopituitarism and associated abnormalities.

Purpose of the Study:

• To determine the role of OTX2 mutations in congenital hypopituitarism, with or without eye abnormalities.
• To investigate the functional consequences of OTX2 variants and its expression patterns in the human brain.
• To elucidate the mechanism of action for OTX2 in endocrine development.

Main Methods:

• Screening of patients with and without eye abnormalities for OTX2 mutations.
• Functional analysis of OTX2 variants using transactivation assays in murine neurons.
• In situ hybridization to study OTX2 expression in human embryonic brain.
• Generation of genetically engineered mice with OTX2 variants.

Main Results:

• OTX2 mutations and deletions were identified in patients with eye abnormalities, with variable penetrance.
• OTX2 truncations significantly reduced transactivation ability, correlating with anophthalmia in mice.
• OTX2 expression was observed in the posterior pituitary and hypothalamus, but not the anterior pituitary, during human embryogenesis.

Conclusions:

• OTX2 mutations are infrequently linked to isolated hypopituitarism without eye abnormalities and exhibit variable penetrance.
• The endocrine phenotypes observed in patients with OTX2 mutations likely originate from hypothalamic dysfunction.
• OTX2's expression pattern suggests a critical role in posterior pituitary and hypothalamic development.